Sleep Medicine · Sleep Apnea, Testing and Treatment (book 2)
Central Sleep Apnea: When the Problem Is Not a Blocked Airway
On this page 6 sections
In 30 seconds
Chapter 10: Central Sleep Apnea: When the Problem Is Not a Blocked Airway
Why this matters
The AASM central sleep apnea guideline emphasizes that treatment should be tied to the underlying etiology and that several targeted options may be considered depending on the cause. That is important because central events can arise from heart failure, medications, altitude, neurologic disease, renal disease, or PAP-related treatment emergence. The label “central apnea” is only the start of the workup.aasm+1
This matters because the wrong reflex is common: see central events, reach for a device, and skip the reason they are happening. But central breathing instability is often a clue, not the diagnosis. If you ignore the cause, you may end up treating the monitor instead of the patient.
The college version
Opening Clinical Case
A patient with heart failure has waxing-and-waning ventilation and recurrent central events. Another patient has a few central apneas during sleep onset but no central sleep apnea syndrome. Those two stories are not the same, even though both include “central apneas.” The fellow’s job is not merely to count the events; it is to identify whether there is a true central apnea syndrome, what is driving it, and whether the pattern is clinically meaningful.pubmed.ncbi.nlm.nih+2
That distinction is the whole chapter in miniature. Central sleep apnea is not just “OSA without obstruction.” It is a breathing-control problem, and the treatment depends on the cause.
What You Should Be Able to Do After This Chapter
By the end of this chapter, you should be able to:
- Distinguish a true central apnea from an obstructive event.
- Recognize normal transitional central events and avoid overdiagnosis.
- Explain ventilatory instability and high loop gain in plain language.
- Identify major etiologic categories of central sleep apnea.
- Recognize Cheyne–Stokes breathing and opioid-associated breathing disorders.
- Differentiate treatment-emergent CSA from a persistent syndrome.
- Choose evaluation steps that focus on the underlying cause.
The Core Concept
A central apnea is an event with reduced or absent airflow and reduced or absent respiratory effort. That differs from obstruction, where effort persists but airflow is blocked. Central hypopneas also exist, but the diagnosis depends on event pattern and clinical context, not just a single absent-flow segment. In other words, central apnea is about control failure, not airway blockage.pubmed.ncbi.nlm.nih+1
Medical explanation: central events occur when the brain’s ventilatory drive drops or fluctuates enough that airflow and effort diminish together. Explain It Like I’m 10: in OSA, the chest tries but air cannot pass. In central apnea, the breathing effort itself temporarily decreases or stops. Back to clinical medicine: to diagnose central apnea correctly, you must look at airflow, effort, frequency, and the broader pattern.
A pattern-based view makes the distinction easier to remember.
Normal Transitional Central Events
Not every central apnea means disease. A few irregular central events can occur during sleep-wake transitions, especially as the brain shifts from wakefulness to sleep. Those isolated events do not automatically establish central sleep apnea syndrome. Frequency, pattern, symptoms, and cause matter.pubmed.ncbi.nlm.nih+1
This is one of the most common overcall traps in sleep medicine. If the patient has a couple of central apneas at sleep onset but no sustained pattern, no relevant symptoms, and no causal context, you should not inflate the finding into a syndrome. The report should describe the events accurately, but the clinician should avoid premature diagnosis. Transitional breathing irregularity is common; syndrome-level pathology is not.
Explain It Like I’m 10: a few irregular breaths while the brain changes from awake mode to sleep mode do not automatically establish a central sleep apnea syndrome. Back to clinical medicine: isolated central events are not the same thing as clinically important CSA.
Ventilatory Control and Loop Gain
Breathing is regulated by feedback control. If the system is overly sensitive, it can overcorrect. That is the idea behind high loop gain. A small change in carbon dioxide may trigger a large ventilatory response, carbon dioxide may fall too low, and breathing may then undershoot, causing central pauses. The cycle can repeat and produce periodic breathing.pubmed.ncbi.nlm.nih+2
Medical explanation: the ventilatory control system behaves like a thermostat that overreacts. When it overshoots, CO₂ can fall below the apneic threshold, breathing pauses, CO₂ rises again, and the pattern repeats. Explain It Like I’m 10: the breathing-control system acts like a thermostat. If it overreacts, breathing may increase too much, carbon dioxide may fall too far, breathing may then decrease, and the cycle may repeat. Back to clinical medicine: ventilatory instability is a useful concept because it helps explain periodic breathing and some forms of central apnea.
Major Etiologic Categories
Central sleep apnea is a syndrome with multiple possible causes, not one disease. Major categories include primary CSA, CSA with heart failure, medication- or substance-related CSA, high-altitude periodic breathing, CSA due to another medical disorder, treatment-emergent CSA, and neurologic or renal contributors. The workup should identify the most plausible category because that determines treatment direction.aasm+1
A useful habit is to ask the cause question before the device question. Is there heart failure? Opioid exposure? Altitude? Neurologic disease? Renal disease? PAP initiation? Each possibility points in a different direction. The label alone is not enough. A patient with central events may need optimization of heart failure therapy, medication review, oxygen at altitude, PAP adjustment, acetazolamide, or another targeted strategy depending on the situation.aasm+1
Cheyne–Stokes Breathing
Cheyne–Stokes breathing is a crescendo-decrescendo pattern of ventilation with central pauses. It is classically associated with heart failure and reflects circulatory delay and ventilatory instability. The pattern is clinically significant because it often signals underlying cardiopulmonary disease and is not just a random waveform wiggle.pubmed.ncbi.nlm.nih+1
The trap is to diagnose it from a single brief snapshot. You need pattern recognition plus clinical context. A few periodic breaths in isolation do not prove Cheyne–Stokes respiration. But when the tracing shows sustained waxing and waning ventilation with central pauses, especially in the setting of heart failure, the diagnosis becomes much more meaningful. That pattern should prompt you to think about heart-failure severity, prognostic significance, and targeted management.pubmed.ncbi.nlm.nih+1
Explain It Like I’m 10: the breathing goes up and down like a wave, and the pauses happen at the low point of the wave. Back to clinical medicine: Cheyne–Stokes breathing is a pattern diagnosis that should trigger etiologic thinking, not just a summary line.
Opioid-Associated Breathing Disorders
Chronic opioid use can suppress respiratory drive and is associated with central sleep apnea, ataxic breathing, and hypoventilation. The association is clinically important and often underrecognized. Medication and substance review is not a formality; it is central to the diagnosis. Dose matters, and co-sedatives can worsen the problem. Coordination with the prescribing clinician may be necessary, especially when changes in analgesic or sedative therapy are being considered.pubmed.ncbi.nlm.nih+2
The trap is to give abrupt or unsafe medication instructions in the sleep clinic. That is not good practice. The correct approach is to identify the relationship between the medication regimen and the sleep-disordered breathing, then coordinate care thoughtfully. Opioid-associated CSA is a breathing-control disorder, not a moral failure or a simple obstruction problem. The history often explains the physiology if you take the time to ask.
Explain It Like I’m 10: some medications quiet the brain’s breathing signal. During sleep, when breathing control already changes, that effect may become more important. Back to clinical medicine: chronic opioid exposure should always be on the shortlist when central or ataxic breathing appears.
High-Altitude Periodic Breathing
High altitude can provoke periodic breathing through hypoxia-driven hyperventilation, carbon dioxide reduction, and subsequent central pauses. The physiology is straightforward: hypoxemia stimulates ventilation, ventilation drops CO₂, and CO₂ can fall enough to trigger central events. Acclimatization may improve things over time, but the pattern can still be clinically relevant.aasm+1
This diagnosis depends on exposure history. If the patient recently ascended to altitude or sleeps at altitude regularly, periodic breathing may be the explanation. Low-flow oxygen and acetazolamide are among the guideline-supported approaches in appropriate cases. The key is to connect the pattern to the environment rather than assuming all central events reflect the same disease mechanism.aasm+1
Treatment-Emergent Central Sleep Apnea
Treatment-emergent CSA occurs when central events appear or persist during PAP treatment in a patient who had obstructive disease at baseline. The important point is that this can be transient. A few early central events do not always mean the patient needs a dramatic mode change. They may resolve with time, pressure adjustment, or better stabilization of sleep and ventilation.aasm+1
The trap is immediate overreaction. If you see a few central events during early PAP use, do not panic-switch the patient into a more complex device before understanding the pattern. Follow-up matters. Some cases are clinically significant and persistent, but others are temporary phenomena during adaptation. That difference is why serial review is part of the diagnosis.
Clinical Evaluation
The evaluation should be etiologic. Ask about medication and substance use, heart failure and ejection fraction when relevant, neurologic disease, renal disease, altitude exposure, and gas-exchange concerns. Review the PSG pattern carefully. Is the breathing periodic? Are there central pauses at sleep onset only? Are there central events during stable sleep? Are there features that suggest hypoventilation rather than pure CSA?pubmed.ncbi.nlm.nih+2
That last distinction matters. Central apnea and hypoventilation are not identical. In CSA, airflow and effort fluctuate or stop in discrete events. In hypoventilation, the issue is sustained inadequate ventilation, often with CO₂ retention. The report and clinical context should help you distinguish them rather than lumping them together for convenience.
Evaluation checklist
- Medication and substance review.
- Cardiac history, and ejection fraction when relevant.
- Neurologic history.
- Renal disease.
- Altitude exposure.
- Gas-exchange or blood-gas concerns.
- PSG pattern review.
- Distinction between CSA and hypoventilation.
Diagnostic Reasoning
Start with the question: are these true CSA events or isolated transitional events? Then ask what is driving the instability. That means looking for heart failure, opioids, altitude, neurologic disease, renal disease, or PAP-emergent instability. Once the etiology is identified, therapy can be matched more intelligently. The AASM guideline supports etiology-specific options, including CPAP, bilevel with backup rate in selected etiologies, ASV in selected cases, oxygen for heart failure- or altitude-related CSA, acetazolamide in selected etiologies, and transvenous phrenic nerve stimulation in certain groups.aasm+1
That does not mean every option is for every patient. The point is to match treatment to mechanism and patient context. A central apnea index is a starting number, not a treatment plan.
Understanding the Relevant Data
The PSG pattern matters as much as the central apnea index. A few sleep-onset events are not a syndrome. A sustained crescendo-decrescendo pattern in heart failure is not a trivial incidental finding. Opioid-associated central events may coexist with hypoventilation or ataxic breathing. Treatment-emergent CSA may shift over time. The report should therefore be read as a physiologic story, not a score sheet.
The device question comes second. If the patient has central instability, the machine choice depends on etiology and context. If the patient has hypoventilation, you may need a different ventilatory strategy. If the problem is medication-related, reviewing and coordinating the medication plan may matter as much as PAP selection. The data guide the treatment, not the other way around.
Return to the Opening Case
The heart-failure patient with waxing and waning ventilation and recurrent central events likely has clinically important CSA or Cheyne–Stokes breathing that deserves etiologic evaluation and targeted management. The patient with several central apneas during sleep onset but no syndrome likely has normal transitional events rather than clinically important CSA. Those are different patients with different implications, even if the report uses the same word “central.”pubmed.ncbi.nlm.nih+2
The right response is not to chase the central apnea index alone. It is to identify the pattern, find the cause, and choose the therapy that fits the cause. That is the central message of central sleep apnea.
What the Attending Will Ask
- What makes an event central? Reduced airflow plus reduced or absent respiratory effort.pubmed.ncbi.nlm.nih+1
- Do isolated sleep-onset central events prove CSA? No. They may be transitional and clinically insignificant.pubmed.ncbi.nlm.nih+1
- What is high loop gain? An overresponsive ventilatory control system that overshoots and undershoots, producing instability.aasm
- What are the major etiologies of CSA? Primary CSA, heart failure, medications or substances, altitude, other medical disorders, treatment-emergent CSA, and neurologic or renal contributors.aasm+1
- What is Cheyne–Stokes breathing? A crescendo-decrescendo breathing pattern with central pauses, often in heart failure.pubmed.ncbi.nlm.nih+1
- Why is opioid review essential? Because opioids can suppress respiratory drive and cause CSA or hypoventilation.pubmed.ncbi.nlm.nih+1
- Can treatment-emergent CSA be transient? Yes. Some cases resolve with follow-up and stabilization.aasm+1
- What is the first question after seeing central events? Are these true central sleep apnea syndrome events or isolated/transition-related events?
Mistakes Smart Fellows Still Make
- Calling every absent-flow event central without reviewing effort. This happens because the airflow channel is most obvious. It matters because obstruction can be missed. Avoid it by checking respiratory effort.
- Diagnosing CSA from occasional sleep-onset events. This happens because central events sound ominous. It matters because transitional events are common. Avoid it by requiring frequency, pattern, symptoms, and cause.
- Ignoring opioid exposure. This happens because the medication list is easy to skim past. It matters because opioids are a major cause. Avoid it by making substance review routine.
- Treating the device rather than the cause. This happens because device changes are tempting. It matters because etiology drives management. Avoid it by working backward from cause.
- Confusing periodic breathing with ordinary obstruction. This happens because both can fragment sleep. It matters because the physiology and treatment differ. Avoid it by pattern recognition.
The Board Exam Is Trying to Trick You
- The stem gives a few central apneas at sleep onset. The trap is to diagnose CSA syndrome. The correct answer is that isolated transitional events are not enough.
- The question shows absent airflow and asks for event type. The trap is to say central without checking effort. The correct answer depends on respiratory effort.
- The stem includes heart failure and waxing-waning ventilation. The trap is to call it ordinary OSA. The correct answer is Cheyne–Stokes breathing / CSA pattern.pubmed.ncbi.nlm.nih+1
- The question includes chronic opioids. The trap is to ignore medication history. The correct answer is opioid-associated breathing disorder.pubmed.ncbi.nlm.nih+1
- The stem shows central events after PAP initiation. The trap is to switch immediately to a complex mode. The correct answer is to consider treatment-emergent CSA and follow-up.aasm+1
How to Explain This to a Patient
“Some sleep breathing problems happen because the airway is blocked, but others happen because the brain’s breathing signal becomes unstable during sleep. We look at the pattern, the medications, the heart, altitude, and other medical conditions to figure out why it is happening. Then we choose the treatment that fits the cause rather than just chasing the number on the report.”
Practical Pearls
- Central apnea is defined by reduced airflow with reduced or absent effort.
- A few sleep-onset central events do not prove disease.
- High loop gain helps explain periodic breathing.
- Heart failure, opioids, altitude, neurologic disease, renal disease, and PAP initiation are major etiologic clues.pubmed.ncbi.nlm.nih+3
- Cheyne–Stokes breathing is a pattern diagnosis, not a single-event diagnosis.pubmed.ncbi.nlm.nih+1
- Opioid-associated CSA requires medication review and coordination.pubmed.ncbi.nlm.nih+1
- Treatment-emergent CSA may be transient and should be followed rather than overreacted to.aasm+1
- CSA and hypoventilation are related but not identical.
- The central apnea index is not the full diagnosis.
- Always ask why the events are happening.
The Bottom Line
- Central apnea is a control problem, not a blocked-airway problem.
- A central event requires reduced airflow and reduced or absent effort.pubmed.ncbi.nlm.nih+1
- Transitional sleep-onset events may be normal and should not be overcalled.
- Ventilatory instability and high loop gain explain periodic breathing.
- Major etiologies include heart failure, opioids, altitude, neurologic disease, renal disease, and treatment-emergent CSA.aasm+1
- Cheyne–Stokes breathing is a crescendo-decrescendo pattern with central pauses.pubmed.ncbi.nlm.nih+1
- Opioids are an important and often overlooked cause of central or ataxic breathing.pubmed.ncbi.nlm.nih+1
- Treatment-emergent CSA can be transient but needs follow-up.
- The treatment should target the cause, not just the index.
- The central apnea number is a clue, not the conclusion.
Question 1
What defines a central apnea?
A. Reduced airflow with preserved effort B. Reduced airflow with reduced or absent respiratory effort C. Loud snoring with arousal D. Airflow obstruction with increased effort only E. Oxygen desaturation without airflow change
Question 2
A patient has two or three central apneas at sleep onset but no other abnormalities. What is the best interpretation?
A. Definite central sleep apnea syndrome B. Normal transitional central events may be present C. Cheyne–Stokes breathing is proven D. Opioid-related CSA is confirmed E. The patient must have hypoventilation
Question 3
What is high loop gain?
A. A low-resistance airway B. An overresponsive ventilatory control system that overshoots and undershoots C. A mask leak pattern D. A measure of nasal obstruction E. The same thing as AHI
Question 4
Which condition is a classic contributor to central sleep apnea and periodic breathing?
A. Heart failure B. Mild allergic rhinitis C. Simple snoring D. Isolated bruxism E. Nasal dryness
Question 5
What is the most appropriate first step when central events are seen on a report?
A. Change to a more complex PAP mode immediately B. Determine whether this is a true central sleep apnea syndrome or isolated/transitional events C. Ignore the finding D. Diagnose OSA only E. Treat with oxygen without evaluation
Question 1
Correct answer: B. Reduced airflow with reduced or absent respiratory effort.
Why it is correct: that is the physiologic definition of a central apnea.pubmed.ncbi.nlm.nih+1 Why the others are wrong: A describes preserved effort, which suggests obstruction; C, D, and E are incomplete or incorrect. Learning point: effort is the key distinction.
Question 2
Correct answer: B. Normal transitional central events may be present.
Why it is correct: a few sleep-onset central events do not establish CSA syndrome.pubmed.ncbi.nlm.nih+1 Why the others are wrong: A, C, D, and E are overcalls. Learning point: frequency and pattern matter.
Question 3
Correct answer: B. An overresponsive ventilatory control system that overshoots and undershoots.
Why it is correct: high loop gain creates unstable breathing with repetitive overshoot and undershoot.aasm Why the others are wrong: A, C, D, and E are unrelated. Learning point: loop gain is a control-system concept.
Question 4
Correct answer: A. Heart failure.
Why it is correct: heart failure is a classic context for CSA and Cheyne–Stokes breathing.pubmed.ncbi.nlm.nih+1 Why the others are wrong: the remaining options are not classic CSA drivers. Learning point: context is part of the diagnosis.
Question 5
Correct answer: B. Determine whether this is a true central sleep apnea syndrome or isolated/transitional events.
Why it is correct: that is the essential first diagnostic question.pubmed.ncbi.nlm.nih+1 Why the others are wrong: A skips diagnosis, C ignores useful data, D may be wrong, and E is too reflexive. Learning point: identify the syndrome before selecting therapy.
Quick check
5 questions here. Answers stay hidden until you check.
A patient has two or three central apneas at sleep onset but no other abnormalities. What is the best interpretation?
What is high loop gain?
Which condition is a classic contributor to central sleep apnea and periodic breathing?
What is the most appropriate first step when central events are seen on a report?
Study tools & related lessonsRelated
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.
